Ozempic Face Treatment NYC: Restoring Facial Volume

Back to Ozempic Face & Body Overview

If you’ve lost weight on a GLP-1 medication, Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, or one of the newer oral options, and feel like your face looks older or more drawn than your body does, you’re likely dealing with volume loss, not accelerated aging. This is one of the more common concerns Dr. Jane Yoo sees at her Midtown Manhattan practice, and it’s directly treatable.

What Is Ozempic Face?

“Ozempic face” has become shorthand for facial hollowing and volume loss following rapid, significant weight loss on any GLP-1 medication, whether it is an injectable or an oral. It shows up as sunken cheeks and temples, deeper nasolabial folds, thinner-looking skin, and an overall more tired or aged appearance, often surprising patients who otherwise feel their healthiest.

Why It’s Volume Loss, Not Aging

It’s an important distinction, because it changes the treatment approach. Photoaging and years of sun exposure can change skin quality, texture, pigmentation, and fine lines. Ozempic face is primarily about the structure underneath: fat pads that used to support the face’s contour have thinned out. That’s why volume restoration, not just skin-quality treatments, is usually central to correcting it.

Treatment Options

Dermal Filler

For patients with more pronounced volume loss, hyaluronic acid filler placed strategically in the cheeks, temples, and along the jawline restores lost structure directly, with results visible immediately.

Biostimulator Injectables (Sculptra)

Sculptra and similar biostimulators work differently from filler. Rather than adding volume directly, they stimulate the body’s own collagen production over a series of sessions, gradually rebuilding facial volume with a result that develops over months and tends to last longer than traditional filler.

RF and HIFU

RF and HIFU are standard parts of Ozempic face treatment, since volume loss is very often accompanied by some degree of skin laxity. These treatments tighten and support the skin itself, complementing the volume restored through filler or Sculptra rather than being reserved for special cases.

Combination Protocols

Most patients get the best results from combining approaches, such as filler for immediate structure, Sculptra for gradual, longer-lasting volume, and RF and HIFU to tighten and support the skin. Dr. Yoo builds each protocol around the degree and location of volume loss specific to the patient.

What to Expect at a Consultation Visit

Consultation includes an assessment of facial volume loss by area, a discussion of your GLP-1 treatment timeline and whether you’re still losing weight or have stabilized, and a customized plan, since treating a patient still actively losing weight differs from treating one who has reached a stable weight.

Frequently Asked Questions

Does Ozempic face go away if I stop the medication?

Regaining weight can restore some facial volume, but it’s not a reliable or recommended fix, and skin laxity that developed during rapid weight loss doesn’t necessarily resolve just because weight is regained. Targeted treatment is a more predictable path.

What’s the difference between dermal filler and Sculptra for Ozempic face?

Filler adds volume directly and gives an immediate result. Sculptra works differently as it stimulates your own collagen production, so results build gradually over months but tend to last longer. Many patients benefit from a combination: filler for immediate structure, Sculptra for gradual, longer-lasting volume.

How soon after starting a GLP-1 medication can I get treatment?

There’s no need to wait until you’ve reached your goal weight. Many patients start treatment while still losing weight, then reassess once weight has stabilized.

Is Ozempic face treatment covered by insurance?

No. These are elective cosmetic treatments and are not typically covered by insurance.

How long do results last?

It depends on the treatment. Filler typically lasts 6–18 months depending on the product and area. Sculptra is done as a series, with results building over months and commonly lasting up to two years, and periodic maintenance is recommended after that.

Book a Consultation!

author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.